![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CARHSP1 |
Gene summary for CARHSP1 |
![]() |
Gene information | Species | Human | Gene symbol | CARHSP1 | Gene ID | 23589 |
Gene name | calcium regulated heat stable protein 1 | |
Gene Alias | CRHSP-24 | |
Cytomap | 16p13.2 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q9Y2V2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23589 | CARHSP1 | GSM4909280 | Human | Breast | Precancer | 2.26e-02 | -6.95e-01 | 0.0305 |
23589 | CARHSP1 | GSM4909281 | Human | Breast | IDC | 2.20e-12 | -3.39e-01 | 0.21 |
23589 | CARHSP1 | GSM4909282 | Human | Breast | IDC | 2.35e-05 | 2.99e-01 | -0.0288 |
23589 | CARHSP1 | GSM4909285 | Human | Breast | IDC | 7.55e-25 | -6.17e-01 | 0.21 |
23589 | CARHSP1 | GSM4909286 | Human | Breast | IDC | 4.64e-26 | -6.84e-01 | 0.1081 |
23589 | CARHSP1 | GSM4909290 | Human | Breast | IDC | 6.64e-08 | -4.40e-01 | 0.2096 |
23589 | CARHSP1 | GSM4909291 | Human | Breast | IDC | 1.05e-02 | -3.74e-01 | 0.1753 |
23589 | CARHSP1 | GSM4909292 | Human | Breast | IDC | 4.37e-04 | -8.38e-01 | 0.1236 |
23589 | CARHSP1 | GSM4909293 | Human | Breast | IDC | 3.58e-20 | -5.83e-01 | 0.1581 |
23589 | CARHSP1 | GSM4909294 | Human | Breast | IDC | 1.12e-12 | -6.31e-01 | 0.2022 |
23589 | CARHSP1 | GSM4909295 | Human | Breast | IDC | 3.23e-06 | -4.46e-01 | 0.0898 |
23589 | CARHSP1 | GSM4909296 | Human | Breast | IDC | 2.26e-16 | -6.20e-01 | 0.1524 |
23589 | CARHSP1 | GSM4909297 | Human | Breast | IDC | 4.69e-24 | -6.93e-01 | 0.1517 |
23589 | CARHSP1 | GSM4909298 | Human | Breast | IDC | 1.76e-17 | -4.67e-01 | 0.1551 |
23589 | CARHSP1 | GSM4909299 | Human | Breast | IDC | 1.30e-12 | -4.78e-01 | 0.035 |
23589 | CARHSP1 | GSM4909301 | Human | Breast | IDC | 3.58e-05 | -3.16e-01 | 0.1577 |
23589 | CARHSP1 | GSM4909302 | Human | Breast | IDC | 3.79e-09 | -5.02e-01 | 0.1545 |
23589 | CARHSP1 | GSM4909303 | Human | Breast | IDC | 1.41e-03 | -5.96e-01 | 0.0438 |
23589 | CARHSP1 | GSM4909304 | Human | Breast | IDC | 1.49e-13 | -4.17e-01 | 0.1636 |
23589 | CARHSP1 | GSM4909305 | Human | Breast | IDC | 2.72e-08 | -3.31e-01 | 0.0436 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00467001 | Colorectum | SER | heterocycle catabolic process | 97/2897 | 445/18723 | 2.20e-04 | 3.89e-03 | 97 |
GO:19013611 | Colorectum | SER | organic cyclic compound catabolic process | 104/2897 | 495/18723 | 5.46e-04 | 7.63e-03 | 104 |
GO:00346551 | Colorectum | SER | nucleobase-containing compound catabolic process | 88/2897 | 407/18723 | 5.53e-04 | 7.71e-03 | 88 |
GO:00194391 | Colorectum | SER | aromatic compound catabolic process | 98/2897 | 467/18723 | 8.09e-04 | 1.01e-02 | 98 |
GO:00064021 | Colorectum | SER | mRNA catabolic process | 54/2897 | 232/18723 | 1.11e-03 | 1.28e-02 | 54 |
GO:00064011 | Colorectum | SER | RNA catabolic process | 62/2897 | 278/18723 | 1.56e-03 | 1.67e-02 | 62 |
GO:00610131 | Colorectum | SER | regulation of mRNA catabolic process | 40/2897 | 166/18723 | 2.37e-03 | 2.25e-02 | 40 |
GO:00434881 | Colorectum | SER | regulation of mRNA stability | 38/2897 | 158/18723 | 3.10e-03 | 2.70e-02 | 38 |
GO:00434871 | Colorectum | SER | regulation of RNA stability | 40/2897 | 170/18723 | 3.72e-03 | 3.09e-02 | 40 |
GO:19033112 | Colorectum | MSS | regulation of mRNA metabolic process | 115/3467 | 288/18723 | 1.23e-17 | 6.41e-15 | 115 |
GO:00064012 | Colorectum | MSS | RNA catabolic process | 102/3467 | 278/18723 | 5.07e-13 | 1.02e-10 | 102 |
GO:00064022 | Colorectum | MSS | mRNA catabolic process | 89/3467 | 232/18723 | 8.70e-13 | 1.60e-10 | 89 |
GO:00442702 | Colorectum | MSS | cellular nitrogen compound catabolic process | 141/3467 | 451/18723 | 2.95e-11 | 3.83e-09 | 141 |
GO:00467002 | Colorectum | MSS | heterocycle catabolic process | 139/3467 | 445/18723 | 4.37e-11 | 5.05e-09 | 139 |
GO:00346552 | Colorectum | MSS | nucleobase-containing compound catabolic process | 129/3467 | 407/18723 | 7.48e-11 | 8.18e-09 | 129 |
GO:00610132 | Colorectum | MSS | regulation of mRNA catabolic process | 66/3467 | 166/18723 | 1.25e-10 | 1.26e-08 | 66 |
GO:19013612 | Colorectum | MSS | organic cyclic compound catabolic process | 148/3467 | 495/18723 | 3.47e-10 | 3.18e-08 | 148 |
GO:00434872 | Colorectum | MSS | regulation of RNA stability | 66/3467 | 170/18723 | 4.14e-10 | 3.49e-08 | 66 |
GO:00434882 | Colorectum | MSS | regulation of mRNA stability | 62/3467 | 158/18723 | 8.41e-10 | 6.81e-08 | 62 |
GO:00194392 | Colorectum | MSS | aromatic compound catabolic process | 140/3467 | 467/18723 | 8.56e-10 | 6.85e-08 | 140 |
Page: 1 2 3 4 5 6 7 8 9 10 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CARHSP1 | SNV | Missense_Mutation | rs201523233 | c.316N>A | p.Glu106Lys | p.E106K | Q9Y2V2 | protein_coding | deleterious(0.03) | possibly_damaging(0.58) | TCGA-5L-AAT1-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | letrozol | SD |
CARHSP1 | SNV | Missense_Mutation | rs770141066 | c.73N>T | p.Arg25Trp | p.R25W | Q9Y2V2 | protein_coding | tolerated(0.07) | possibly_damaging(0.652) | TCGA-MA-AA41-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
CARHSP1 | SNV | Missense_Mutation | rs368130205 | c.79N>T | p.Arg27Cys | p.R27C | Q9Y2V2 | protein_coding | deleterious(0) | benign(0.18) | TCGA-AD-6964-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | folfox | PD |
CARHSP1 | deletion | Frame_Shift_Del | c.258delC | p.Asp87ThrfsTer140 | p.D87Tfs*140 | Q9Y2V2 | protein_coding | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |||
CARHSP1 | SNV | Missense_Mutation | rs201523233 | c.316N>A | p.Glu106Lys | p.E106K | Q9Y2V2 | protein_coding | deleterious(0.03) | possibly_damaging(0.58) | TCGA-A5-A2K3-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
CARHSP1 | SNV | Missense_Mutation | c.281N>C | p.Asp94Ala | p.D94A | Q9Y2V2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D1-A17D-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | |
CARHSP1 | SNV | Missense_Mutation | rs201523233 | c.316N>A | p.Glu106Lys | p.E106K | Q9Y2V2 | protein_coding | deleterious(0.03) | possibly_damaging(0.58) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CARHSP1 | SNV | Missense_Mutation | c.8N>G | p.Ser3Cys | p.S3C | Q9Y2V2 | protein_coding | deleterious_low_confidence(0) | benign(0.358) | TCGA-18-4083-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD | |
CARHSP1 | deletion | Frame_Shift_Del | novel | c.296_299delNNNN | p.Tyr99SerfsTer127 | p.Y99Sfs*127 | Q9Y2V2 | protein_coding | TCGA-TP-A8TT-01 | Prostate | prostate adenocarcinoma | Male | <65 | 7 | Unknown | Unknown | SD | ||
CARHSP1 | SNV | Missense_Mutation | rs201523233 | c.316N>A | p.Glu106Lys | p.E106K | Q9Y2V2 | protein_coding | deleterious(0.03) | possibly_damaging(0.58) | TCGA-BR-4371-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |